226 related articles for article (PubMed ID: 31521697)
1. Targeting epigenetic machinery: Emerging novel allosteric inhibitors.
Ye F; Huang J; Wang H; Luo C; Zhao K
Pharmacol Ther; 2019 Dec; 204():107406. PubMed ID: 31521697
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
3. Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics.
Bao Q; Kumar A; Wu D; Zhou J
Drug Discov Today; 2024 Jun; 29(6):103986. PubMed ID: 38642703
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics in Cystic Fibrosis: Epigenetic Targeting of a Genetic Disease.
Sirinupong N; Yang Z
Curr Drug Targets; 2015; 16(9):976-87. PubMed ID: 25882215
[TBL] [Abstract][Full Text] [Related]
5. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
Liang Z; Zhu Y; Liu X; Hu G
Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
[TBL] [Abstract][Full Text] [Related]
6. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer.
Mohammad HP; Barbash O; Creasy CL
Nat Med; 2019 Mar; 25(3):403-418. PubMed ID: 30842676
[TBL] [Abstract][Full Text] [Related]
7. Targeting epigenetic DNA and histone modifications to treat kidney disease.
Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
[TBL] [Abstract][Full Text] [Related]
8. Histone methyltransferase inhibitors: novel epigenetic agents for cancer treatment.
Zagni C; Chiacchio U; Rescifina A
Curr Med Chem; 2013; 20(2):167-85. PubMed ID: 23210854
[TBL] [Abstract][Full Text] [Related]
9. Targeting chromatin readers.
James LI; Frye SV
Clin Pharmacol Ther; 2013 Apr; 93(4):312-4. PubMed ID: 23403847
[TBL] [Abstract][Full Text] [Related]
10. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
Morera L; Lübbert M; Jung M
Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
[TBL] [Abstract][Full Text] [Related]
11. An update on allosteric modulators as a promising strategy targeting histone methyltransferase.
Tan Z; Li T; Lei H; Zhai X
Pharmacol Res; 2021 Oct; 172():105865. PubMed ID: 34474102
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic pathways in macrophages emerge as novel targets in atherosclerosis.
Neele AE; Van den Bossche J; Hoeksema MA; de Winther MP
Eur J Pharmacol; 2015 Sep; 763(Pt A):79-89. PubMed ID: 26004034
[TBL] [Abstract][Full Text] [Related]
13. A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine.
Catalano R; Rocca R; Juli G; Costa G; Maruca A; Artese A; Caracciolo D; Tagliaferri P; Alcaro S; Tassone P; Amodio N
Eur J Med Chem; 2019 Dec; 183():111715. PubMed ID: 31550663
[TBL] [Abstract][Full Text] [Related]
14. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms.
Martinez ED; Gazdar AF
Epigenomics; 2016 Mar; 8(3):313-6. PubMed ID: 26918824
[No Abstract] [Full Text] [Related]
17. Epigenetic modulators as therapeutic targets in prostate cancer.
Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions.
Lin J; Wang C; Kelly WK
Semin Oncol; 2013 Jun; 40(3):393-401. PubMed ID: 23806502
[TBL] [Abstract][Full Text] [Related]
19. Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions.
Zhu Y; Ye F; Zhou Z; Liu W; Liang Z; Hu G
Molecules; 2021 Aug; 26(17):. PubMed ID: 34500587
[TBL] [Abstract][Full Text] [Related]
20. The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy.
Liu N; Zhao R; Ma Y; Wang D; Yan C; Zhou D; Yin F; Li Z
Curr Top Med Chem; 2018; 18(28):2380-2394. PubMed ID: 30430946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
